comparemela.com
  1. Home
  2. Live Updates
  3. Affairs At Xeris - Breaking News

Affairs At Xeris News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Recorlev Now Available for Endogenous Hypercortisolemia in Cushing Syndrome

Recorlev (levoketoconazole) is now available for the treatment of endogenous hypercortisolemia in adults with Cushing syndrome.

Xeris biopharmaXeris careconnectionKen johnsonPaulr edickGlobal developmentAffairs at xerisMedical affairsBoxed warningAccessed january

Xeris Biopharma Announces Recorlev® (levoketoconazole) Is Now Commercially Available for the Treatment of Endogenous Hypercortisolemia in Adult Patients With Cushing s Syndrome | Illinois

CHICAGO (BUSINESS WIRE) Jan 31, 2022

United statesLindsay roccoAllison weyXeris biopharmaStrongbridge biopharmaXeris careconnectionPaulr edickKen johnsonXeris pharmaceuticalsGlobal developmentXeris biopharma holdingsXeris pharmaceuticals incPantherx rareElixir healthDrug administrationPatient assistance program

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.